CD314 (NKG2D) Antibody, anti-human, APC, REAfinity™ 130-111-846 from Miltenyi Biotec | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
Miltenyi Biotec for
CD314 (NKG2D) Antibody, anti-human, APC, REAfinity™

The CD314 (NKG2D) Antibody, anti-human, APC, REAfinity™ from Miltenyi Biotec is a Human Monoclonal antibody to KLRK1. This antibody recognizes Human, and Non-Human Primate antigen. The CD314 (NKG2D) Antibody, anti-human, APC, REAfinity™ has been validated for the following applications: Flow Cytometry.

Product Specs
ItemCD314 (NKG2D) Antibody, anti-human, APC, REAfinity™
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-111-846
Quantity100 tests in 200 µL
ApplicationsFlow cytometry
Conjugate/TagAPC
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
IsotypeIgG1
CloneREA797
Hosthuman cell line
Antibody TypePrimary antibodies, Recombinant antibodies
NCBI Full Gene Namekiller cell lectin like receptor K1
NCBI Gene AliasesCD314, D12S2489E, KLR, NKG2-D, NKG2D
Clonalitymonoclonal
Reactivityhuman, non-human primate
Concentration1:50
ModificationsRecombinantly engineered
TargetCD314 (NKG2D)
Research AreaFor research use only
Regulatory StatusFor research use only

Add to Compare List

Miltenyi Biotec

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1) Phase I clinical trial combining imatinib mesylate and IL-2: HLA-DR⁺ NK cell levels correlate with disease outcomeOncoimmunologyFebruary 1, 2013Chaput N, Flament C, Locher C, Desbois M, Rey A, Rusakiewicz S, Poirier-Colame V, Pautier P, Le Cesne A, Soria JC, et al.

(2) The Eighth Human Leucocyte Differentiation Antigen (HLDA8) Workshop: natural killer cell section reportCellular immunologyJuly 1, 2005Warren HS.

(3) NKG2D is a costimulatory receptor for human naive CD8+ T cellsJournal of immunology (Baltimore, Md. : 1950)April 15, 2005Maasho K, Opoku-Anane J, Marusina AI, Coligan JE, Borrego F.

(4) Unravelling natural killer cell function: triggering and inhibitory human NK receptorsThe EMBO journalJanuary 28, 2004Moretta L, Moretta A.

(5) Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritisProceedings of the National Academy of Sciences of the United States of AmericaAugust 5, 2003Groh V, Bruhl A, El-Gabalawy H, Nelson JL, Spies T.

(6) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICAScience (New York, N.Y.)July 30, 1999Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T.

Be the First to Write a Review!